Treatment outcomes and prognostic factors in adult patients

  • Slides: 7
Download presentation
Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated

Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy by Jae-Ho Yoon, Sung-Soo Park, Young-Woo Jeon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, and Jong Wook Lee haematol Volume 104(2): 269 -276 January 31, 2019 © 2019 by Ferrata Storti Foundation

Consort diagram of enrolled patients. Jae-Ho Yoon et al. Haematologica 2019; 104: 269 -276

Consort diagram of enrolled patients. Jae-Ho Yoon et al. Haematologica 2019; 104: 269 -276 © 2019 by Ferrata Storti Foundation

Baseline characteristics and treatment outcome of patients with non-malignancy-associated secondary HLH (n=126). Jae-Ho Yoon

Baseline characteristics and treatment outcome of patients with non-malignancy-associated secondary HLH (n=126). Jae-Ho Yoon et al. Haematologica 2019; 104: 269 -276 © 2019 by Ferrata Storti Foundation

Survival outcomes according to the cause of secondary hemophagocytic lymphohistiocytosis. Jae-Ho Yoon et al.

Survival outcomes according to the cause of secondary hemophagocytic lymphohistiocytosis. Jae-Ho Yoon et al. Haematologica 2019; 104: 269 -276 © 2019 by Ferrata Storti Foundation

Survival outcomes according to treatment response. Jae-Ho Yoon et al. Haematologica 2019; 104: 269

Survival outcomes according to treatment response. Jae-Ho Yoon et al. Haematologica 2019; 104: 269 -276 © 2019 by Ferrata Storti Foundation

Univariate and multivariate analyses for parameters affecting overall survival in non-malignancyassociated HLH. Jae-Ho Yoon

Univariate and multivariate analyses for parameters affecting overall survival in non-malignancyassociated HLH. Jae-Ho Yoon et al. Haematologica 2019; 104: 269 -276 © 2019 by Ferrata Storti Foundation

Survival outcomes according to hemophagocytic lymphohistiocytosis risk score. Jae-Ho Yoon et al. Haematologica 2019;

Survival outcomes according to hemophagocytic lymphohistiocytosis risk score. Jae-Ho Yoon et al. Haematologica 2019; 104: 269 -276 © 2019 by Ferrata Storti Foundation